Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cue Biopharma, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cue Biopharma, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Cue Biopharma, Inc. since 2005.
The reporting company's ticker symbol is CUE. The reporting company's CIK number is 1645460.
The total value of stock buying since 2005 is $838,523.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-31||Marlett Christopher A (Director)||Buy||18,521||4.64||85,937|
|2018-12-28||Digiandomenico Anthony (Director)||Buy||7,000||4.62||32,340|
|2018-12-27||Digiandomenico Anthony (Director)||Buy||20,000||4.77||95,399|
|2018-12-26||Marlett Christopher A (Director)||Buy||19,647||4.29||84,285|
|2018-12-24||Digiandomenico Anthony (Director)||Buy||10,000||4.81||48,099|
|2018-12-21||Suri Anish (Chief Scientific Officer)||Buy||2,000||4.37||8,740|
|2018-12-21||Digiandomenico Anthony (Director)||Buy||10,000||4.49||44,900|
|2018-12-21||Marlett Christopher A (Director)||Buy||17,200||4.53||77,916|
|2018-12-20||Marlett Christopher A (Director)||Buy||9,438||4.74||44,736|
|2018-12-19||Marlett Christopher A (Director)||Buy||400||5.00||2,000|
|2018-12-18||Marlett Christopher A (Director)||Buy||3,664||5.20||19,052|
|2018-12-17||Digiandomenico Anthony (Director)||Buy||10,000||5.48||54,800|
|2018-12-13||Marlett Christopher A (Director)||Buy||10,000||5.06||50,599|
|2018-12-12||Marlett Christopher A (Director)||Buy||12,189||5.08||61,920|
|2018-12-11||Marlett Christopher A (Director)||Buy||7,543||4.86||36,658|
|2018-08-29||Millar Kerri-ann (VP-Finance)||Buy||1,000||8.48||8,480|
|2018-08-16||Passeri Daniel R (CEO and President)||Buy||6,000||8.09||48,510|
|2018-06-29||Passeri Daniel R (CEO and President)||Buy||1,600||11.97||19,152|
|2017-12-27||Pienta Kenneth (Chief Medical Officer)||Buy||2,000||7.50||15,000|
Insider trading activities including stock purchases, stock sales, and option exercises of CUE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cue Biopharma, Inc. (symbol CUE, CIK number 1645460) see the Securities and Exchange Commission (SEC) website.